Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.6026/97320630016236

http://scihub22266oqcxt.onion/10.6026/97320630016236
suck pdf from google scholar
32308266!7147498!32308266
unlimited free pdf from europmc32308266    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid32308266
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus #MMPMID32308266
  • Odhar HA; Ahjel SW; Albeer AAMA; Hashim AF; Rayshan AM; Humadi SS
  • Bioinformation 2020[]; 16 (3): 236-244 PMID32308266show ga
  • Design and development of an effective drug to combat the 2019 novel coronavirus remains a challenge. Therefore, it is of interest to study the binding features of 1615 FDA approved drugs with the recently known 2019-nCoV main protease structure having high sequence homology with that from SARS-CoV. We document the binding features of top 10 drugs with the target protein. We further report that Conivaptan and Azelastine are mainly involved in hydrophobic interactions with active site residues. Both drugs can maintain close proximity to the binding pocket of main protease during simulation. However, these data need further in vitro and in vivo evaluation to repurpose these two drugs against 2019-nCoV.
  • ä


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    236 3.16 2020